Calcitonin gene-related peptide type 1 receptor — Drug Target

All drugs that target Calcitonin gene-related peptide type 1 receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Calcitonin Gene-related Peptide Receptor Antagonist [EPC] · Calcitonin Gene-related Peptide Receptor Antagonist

Marketed (3)

• Ubrelvy · AbbVie · Calcitonin Gene-related Peptide Receptor Antagonist [EPC] · Neuroscience
  Ubrelvy blocks the action of a molecule called calcitonin gene-related peptide, which is involved in migraine pain.
• Qulipta · AbbVie · Calcitonin Gene-related Peptide Receptor Antagonist [EPC] · Neuroscience
  Qulipta works by blocking the action of a natural chemical called calcitonin gene-related peptide type 1, which is involved in migraine pain.
• Zavzpret · Pfizer · Calcitonin Gene-related Peptide Receptor Antagonist · Neuroscience
  Zavzpret blocks the action of calcitonin gene-related peptide, a molecule involved in pain transmission.